Wellcome is a politically and financially independent foundation that exists to improve health by supporting researchers and tackling major health challenges.
Portfolio
2
companies
Kymab
Kymab develops proprietary human monoclonal antibody therapeutics for serious diseases.
Transformative
Transformative builds software that predicts sudden cardiac arrest using hospital patient monitoring data.
Tera Ventures led the seed financing round for the medical software startup, with participation from the Wellcome Trust and InHealth Ventures.
"On each shift, I experience the tragedy of delayed care and the marvel of early, preventive interventions,"
The series C round was led by ORI Fund and will support clinical development of the company antibody pipeline.
